States Lack Uniform Rules for AI Health Liability - Legis1
Reported by Legis1 · all stories from legis1.com
Editorial digest
Across various states, there is an absence of standardized rules concerning liability when artificial intelligence is used in healthcare settings. This creates regulatory uncertainty.
Digests are written in our own words from the publisher's headline — we never reproduce article text. Read the original for the full reporting.
Read the full story at Legis1 →More like this
Other stories our editors tagged with the same themes.
- Trusted health newsroom8/24/2026
STAT+: FDA digital health leader promises generative AI regulatory guidance is coming
FDA digital health head confirms generative AI regulatory guidelines are in development.
- Reputable trade press8/19/2026
Nearly All FDA-Cleared AI Medical Devices Lack Evidence of Patient Benefit - Inside Precision Medicine
Most FDA-approved AI medical devices lack strong evidence of direct patient benefit.
- Trusted health newsroom9/3/2026
STAT+: FDA pilot offers generative AI medical devices a path to patients before they are authorized
FDA pilot program allows generative AI devices to reach patients pre-authorization.
- Trusted health newsroom9/1/2026
STAT+: FDA clears Stryker’s ‘surgical cockpit’ that uses Apple’s VR headset, Vision Pro
Stryker's system for surgery, using Apple Vision Pro, received FDA clearance.
- Official source7/23/2026
Digital Health Technologies (DHTs) for Drug Development - fda.gov
The FDA issued guidance on Digital Health Technologies for drug development.
- Trusted health newsroom8/27/2026
STAT+: CMS plans launch event for ACCESS, the Medicare chronic care pilot
CMS is preparing an event for its new chronic care pilot, ACCESS.